Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - asciminibum - compresse rivestite con film - asciminibum 20 mg ut asciminibi hydrochloridum 21.62 mg, lactosum monohydricum 43.11 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, carmellosum natricum conexum, poly(alcohol vinylicus), e 171, magnesii stearas, talcum, silica colloidalis anhydrica, lecithinum, e 172 (flavum), e 172 (rubrum), xanthani gummi, pro compresso obducto corresp. natrium max. 0.47 mg. - behandlung von erwachsenen patienten mit philadelphia-chromosom-positiver chronisch-myeloischer leukämie (ph+ cml) in der chronischen phase (cp) - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - asciminibum - compresse rivestite con film - asciminibum 40 mg ut asciminibi hydrochloridum 43.24 mg, lactosum monohydricum 86.22 mg, cellulosum microcristallinum, hydroxypropylcellulosum substitutum humile, carmellosum natricum conexum, poly(alcohol vinylicus), e 171, magnesii stearas, talcum, silica colloidalis anhydrica, lecithinum, e 172 (rubrum), e 172 (nigrum), xanthani gummi, pro compresso obducto corresp. natrium max. 0.93 mg. - behandlung von erwachsenen patienten mit philadelphia-chromosom-positiver chronisch-myeloischer leukämie (ph+ cml) in der chronischen phase (cp) - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - dexamethasonum, neomycinum, polymyxini b sulfas - collirio - dexamethasonum 1 mg, neomycinum 3.5 mg ut neomycini sulfas 4.6 mg, polymyxini b sulfas 6000 u.i., natrii chloridum, polysorbatum 20, acidum hydrochloridum aut natrii hydroxidum, hypromellosum, aqua purificata, benzalkonii chloridum 40 µg, ad suspensionem pro 1 ml. - infetti infiammazione agli occhi - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - tobramycinum - collirio - tobramycinum 3 mg, acidum boricum 12.4 mg, natrii sulfas anhydricus, tyloxapolum, natrii hydroxidum aut acidum sulfuricum, natrii chloridum, aqua purificata, benzalkonii chloridum 0.1 mg, ad solutionem pro 1 ml. - batterica, infezioni agli occhi - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - tobramycinum - il collirio - tobramycinum 3 mg, paraffinum liquidum, vaselinum album, chlorobutanolum, ad unguentum pro 1 g. - batterica, infezioni agli occhi - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - dexamethasonum, tobramycinum - augentropfensuspension - dexamethasonum 1 mg, tobramycinum 3 mg, dinatrii edetas, natrii chloridum, natrii sulfas, tyloxapolum, hydroxyethylcellulosum, aqua, natrii hydroxidum aut acidum sulfuricum, benzalkonii chloridum 0.1 mg, ad suspensionem pro 1 ml. - batterica, infezioni agli occhi - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - dexamethasonum, tobramycinum - il collirio - dexamethasonum 1 mg, tobramycinum 3 mg, paraffinum liquidum, vaselinum album, chlorobutanolum, ad unguentum pro 1 g. - batterica, infezioni agli occhi - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - travoprostum - collirio - travoprostum 40 µg, macrogolglyceroli hydroxystearas 2 mg, propylenglycolum, acidum boricum, mannitolum, natrii chloridum, polyquaternium-1, acidum hydrochloridum aut natrii hydroxidum ad ph, aqua purificata q.s. ad solutionem pro 1 ml. - il glaucoma - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - olopatadinum - collirio - olopatadinum 1 mg ut olopatadini hydrochloridum, benzalkonii chloridum 0.1 mg, natrii chloridum, dinatrii phosphas dodecahydricus corresp. phosphas 3.34 mg, acidum hydrochloridum aut natrii hydroxidum ad ph, aqua purificata, q.s. ad solutionem pro 1 ml. - congiuntivite allergica - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - everolimusum - compresse - everolimusum 0.5 mg, lactosum monohydricum 4.45 mg, hypromellosum, magnesio stearas, crospovidonum, lactosum 74.38 mg, e 321, pro compresso. - profilassi di organabstossungen - biotechnologika